Naohito Ohashi - Concepedia

Author

Naohito Ohashi

Also Known As

N Ohashi, N. OHASHI, N. Ohashi, NAOHITO OHASHI, Naohito OHASHI, Naohito Ohashi, Naohito. Ohashi, Noa Ohashi, Norio OHASHI

101

Publications

1.5K

Citations

H-Index

Concepts

All Affiliations

Sumitomo Dainippon Pharma (Japan)Sumitomo Chemical (Japan)Aichi Medical University Osaka University of Pharmaceutical Sciences Hamamatsu University School of Medicine

About

Naohito Ohashi is an author at Sumitomo Dainippon Pharma (Japan) specializing in medicine, pharmacology, and physiology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	17	23	640
2	Engineering	6	6	246
3	Natural Sciences	6	6	303
4	Health Sciences	1	1	11
5	Public Health	1	1	19

Naohito Ohashi

Publications

Citations

H-Index

Page 1

	Year	Citations
Synthesis of (.+-.)-fredericamycin A T. Ross Kelly, Stephen H. Bell, Naohito Ohashi, Journal of the American Chemical Society Bioorganic ChemistryEngineeringChemical AnalysisAltmetric Attention ScoreBibliometrics	1988	111
Stereospecific total synthesis of 9-aminoanthracyclines: (+)-9-amino-9-deoxydaunomycin and related compounds K. ISHIZUMI, Naohito Ohashi, Norihiko Tanno The Journal of Organic Chemistry Medicinal ChemistryNaohito OhashiBioorganic ChemistryBiochemistryNatural Sciences	1987	87
Na <sup>+</sup> /H <sup>+</sup> Exchanger Inhibitor, SM-20220, Is Protective Against Excitotoxicity in Cultured Cortical Neurons Yuji Matsumoto, Seiji Yamamoto, Y. Suzuki, Stroke	2003	60
SM-20220, a Na+/H+ exchanger inhibitor: effects on ischemic brain damage through edema and neutrophil accumulation in a rat middle cerebral artery occlusion model Y. Suzuki, Yuji Matsumoto, Yasuhiko Ikeda, Brain Research Oxidative StressNeuroinflammationInflammationCerebral Vascular RegulationStroke	2002	48
Cerebroprotective properties of SM-20220, a potent Na+/H+ exchange inhibitor, in transient cerebral ischemia in rats Yoshikazu Kuribayashi, Natsuko Itoh, Masahumi Kitano, European Journal of Pharmacology Cerebral Vascular RegulationTransient Cerebral IschemiaReperfusion InjuryMedicineNeuropharmacology	1999	47
Synthesis of (.+-.)-fredericamycin A T. Ross Kelly, Naohito Ohashi, Rosemary J. Armstrong-Chong, Journal of the American Chemical Society Bioorganic ChemistryEngineeringChemical AnalysisAltmetric Attention ScoreBibliometrics	1986	46
Pharmacological Characterization of a Novel Sulfonylureid-Pyrazole Derivative, SM-19712, a Potent Nonpeptidic Inhibitor of Endothelin Converting Enzyme Kayo Umekawa, Hirohiko Hasegawa, Y Tsutsumi, The Japanese Journal of Pharmacology Pharmacological CharacterizationBig Endothelin-1PharmacotherapyAcute Myocardial InfarctionInflammation	2000	42
SM-20220, a Potent Na+/H+ Exchange Inhibitor, Improves Consciousness Recovery and Neurological Outcome Following Transient Cerebral Ischaemia in Gerbils Yoshikazu Kuribayashi, Natsuko Itoh, Naotsugu Horikawa, Journal of Pharmacy and Pharmacology Social SciencesCerebral Vascular RegulationNeurovascular DiseaseCerebroprotective EffectNeurobiology Of Disease	2000	36
The Na<sup>+</sup>/H<sup>+</sup> Exchanger SM-20220 Attenuates Ischemic Injury in in vitro and in vivo Models Naotsugu Horikawa, Mizue Nishioka, Natsuko Itoh, Pharmacology Biomedical ResearchLipid PeroxidationCell DeathRedox BiologyCellular Physiology	2001	35
Long-term evaluation of recombinant human bone morphogenetic protein-2 induced bone formation with a biologic and synthetic delivery system Cansu Alpaslan, K. Irie, Koichiro Takahashi, British Journal of Oral and Maxillofacial Surgery Tissue EngineeringRegenerative MedicineSynthetic Bone SubstituteDevelopmental BiologyEngineering	1996	32

Page 1